The optical coherence tomography (oct) for healthcare and life science market size has grown rapidly in recent years. It will grow from $2.26 billion in 2025 to $2.63 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing prevalence of eye disorders, expansion of ophthalmic diagnostic procedures, technological advancements in optical imaging, growth of specialty eye clinics, early adoption in research applications.
The optical coherence tomography (oct) for healthcare and life science market size is expected to see rapid growth in the next few years. It will grow to $4.77 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to increasing demand for point-of-care diagnostics, rising adoption in cardiology and dermatology, expansion of tele-ophthalmology services, growing investments in imaging technology innovation, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of ai-assisted image analysis, rising demand for high-resolution non-invasive imaging, growing use of portable and handheld oct devices, expansion of oct applications beyond ophthalmology, enhanced integration with digital health platforms.
The increasing incidence of ocular diseases is expected to drive the growth of the optical coherence tomography (OCT) for healthcare and life science market in the coming years. Ocular diseases are conditions that affect the eyes and surrounding structures and can lead to vision impairment or blindness. The rising occurrence of these diseases is largely associated with an aging population and the growing prevalence of chronic conditions such as diabetes. Optical coherence tomography (OCT) is widely used to generate high-resolution, cross-sectional images of the retina and optic nerve, supporting the diagnosis and monitoring of various ocular conditions. For example, according to the Review of Optometry, a US-based publication providing insights and updates on eye care, approximately 80 million people worldwide are affected by glaucoma, with open-angle glaucoma (OAG) accounting for about 95% of cases. In the United States alone, more than three million individuals are currently living with the condition, and this number is projected to exceed 111 million globally by 2040. Therefore, the growing incidence of ocular diseases is expected to propel the optical coherence tomography (OCT) for healthcare and life science market.
Companies operating in the optical coherence tomography (OCT) for healthcare and life science market are focusing on the development of advanced solutions, such as multi-function ophthalmic diagnostic devices, to improve clinical efficiency. Ophthalmic diagnostic devices are designed to assess eye health and support the detection and monitoring of vision-related disorders. For instance, in July 2025, Huvitz, a South Korea-based manufacturer of ophthalmic and dental equipment, launched the OCTavius ophthalmic diagnostic device. This 5-in-1 OCT system integrates multiple eye-diagnostic functions into a single platform, reducing reliance on separate instruments. It enhances workflow efficiency by delivering rapid scans and high-quality imaging, enabling smoother clinical operations. The device captures detailed structural information of the macula and choroid, allowing comprehensive, layer-specific evaluation and supporting early disease detection and accurate clinical decision-making in ophthalmology.
In July 2024, EssilorLuxottica SA, a France-based eyewear corporation, acquired an 80% stake in Heidelberg Engineering Inc. for an undisclosed amount. This acquisition strengthens EssilorLuxottica’s medical technology capabilities by incorporating advanced optical coherence tomography solutions into its clinical and diagnostic ecosystem. It also expands the company’s presence in high-precision ophthalmic imaging, supporting improved patient care and clinical outcomes. Heidelberg Engineering Inc. is a Germany-based medical equipment company specializing in the development of optical coherence tomography devices for healthcare.
Major companies operating in the optical coherence tomography (oct) for healthcare and life science market are Abbott Laboratories, Canon Inc., Carl Zeiss Meditec AG, Leica Microsystems GmbH, Thorlabs Inc., Edmund Optics Inc., Huvitz Co. Ltd., Santec Corporation, Topcon Medical Systems Inc., OPTOPOL Technology SA, NinePoint Medical, Wasatch Photonics Inc., Perimeter Medical Imaging AI Inc., Nidek Co. Ltd., Novacam Technologies Inc., DermaLumics, BaySpec Inc., Imalux Corporation, Lumedica, Heidelberg Engineering GmbH.
North America was the largest region in the optical coherence tomography (OCT) for healthcare and life science market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical coherence tomography (oct) for healthcare and life science market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the optical coherence tomography (oct) for healthcare and life science market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the OCT for healthcare and life science market by increasing costs of imported optical components, lasers, sensors, and precision imaging modules. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging systems, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are raising equipment procurement costs and delaying technology upgrades. However, they are also encouraging local assembly, regional supplier development, and innovation in cost-efficient OCT system designs.
The optical coherence tomography (oct) for healthcare and life science market research report is one of a series of new reports that provides optical coherence tomography (oct) for healthcare and life science market statistics, including optical coherence tomography (oct) for healthcare and life science industry global market size, regional shares, competitors with a optical coherence tomography (oct) for healthcare and life science market share, detailed optical coherence tomography (oct) for healthcare and life science market segments, market trends and opportunities, and any further data you may need to thrive in the optical coherence tomography (oct) for healthcare and life science industry. This optical coherence tomography (oct) for healthcare and life science market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Optical coherence tomography (OCT) is a non-invasive imaging method that employs light to produce high-resolution cross-sectional images of tissues. It is predominantly utilized in ophthalmology for examining the retina and identifying various eye conditions, but it also finds uses in other medical areas for in-depth tissue imaging and evaluation. This technique offers detailed, non-invasive imaging of tissues, facilitating accurate diagnosis and monitoring of conditions in both ophthalmology and other medical disciplines.
The primary categories of optical coherence tomography (OCT) used in healthcare and life sciences include catheter-based OCT devices, Doppler OCT devices, handheld OCT devices, and tabletop OCT devices. Catheter-based OCT devices are imaging instruments employed in medical procedures that provide high-resolution images of blood vessels and internal structures during minimally invasive interventions. The technology encompasses time domain OCT (TdOCT), frequency domain OCT (FdOCT), and others, with applications across fields such as ophthalmology, cardiology, dermatology, and gastroenterology. The end users of these devices include hospitals, specialty clinics, research institutions, and more.
The optical coherence tomography (OCT) for healthcare and life science markets consists of revenues earned by entities by providing services such as high-resolution imaging and diagnostics for medical conditions, including device sales, maintenance, software solutions, and technical support across various medical fields such as ophthalmology, cardiology, and dermatology. The market value includes the value of related goods sold by the service provider or included within the service offering. The optical coherence tomography (OCT) for healthcare and life science markets also includes sales of imaging systems, accessories including lenses and probes, software for data analysis, and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The optical coherence tomography (oct) for healthcare and life science market size is expected to see rapid growth in the next few years. It will grow to $4.77 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to increasing demand for point-of-care diagnostics, rising adoption in cardiology and dermatology, expansion of tele-ophthalmology services, growing investments in imaging technology innovation, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of ai-assisted image analysis, rising demand for high-resolution non-invasive imaging, growing use of portable and handheld oct devices, expansion of oct applications beyond ophthalmology, enhanced integration with digital health platforms.
The increasing incidence of ocular diseases is expected to drive the growth of the optical coherence tomography (OCT) for healthcare and life science market in the coming years. Ocular diseases are conditions that affect the eyes and surrounding structures and can lead to vision impairment or blindness. The rising occurrence of these diseases is largely associated with an aging population and the growing prevalence of chronic conditions such as diabetes. Optical coherence tomography (OCT) is widely used to generate high-resolution, cross-sectional images of the retina and optic nerve, supporting the diagnosis and monitoring of various ocular conditions. For example, according to the Review of Optometry, a US-based publication providing insights and updates on eye care, approximately 80 million people worldwide are affected by glaucoma, with open-angle glaucoma (OAG) accounting for about 95% of cases. In the United States alone, more than three million individuals are currently living with the condition, and this number is projected to exceed 111 million globally by 2040. Therefore, the growing incidence of ocular diseases is expected to propel the optical coherence tomography (OCT) for healthcare and life science market.
Companies operating in the optical coherence tomography (OCT) for healthcare and life science market are focusing on the development of advanced solutions, such as multi-function ophthalmic diagnostic devices, to improve clinical efficiency. Ophthalmic diagnostic devices are designed to assess eye health and support the detection and monitoring of vision-related disorders. For instance, in July 2025, Huvitz, a South Korea-based manufacturer of ophthalmic and dental equipment, launched the OCTavius ophthalmic diagnostic device. This 5-in-1 OCT system integrates multiple eye-diagnostic functions into a single platform, reducing reliance on separate instruments. It enhances workflow efficiency by delivering rapid scans and high-quality imaging, enabling smoother clinical operations. The device captures detailed structural information of the macula and choroid, allowing comprehensive, layer-specific evaluation and supporting early disease detection and accurate clinical decision-making in ophthalmology.
In July 2024, EssilorLuxottica SA, a France-based eyewear corporation, acquired an 80% stake in Heidelberg Engineering Inc. for an undisclosed amount. This acquisition strengthens EssilorLuxottica’s medical technology capabilities by incorporating advanced optical coherence tomography solutions into its clinical and diagnostic ecosystem. It also expands the company’s presence in high-precision ophthalmic imaging, supporting improved patient care and clinical outcomes. Heidelberg Engineering Inc. is a Germany-based medical equipment company specializing in the development of optical coherence tomography devices for healthcare.
Major companies operating in the optical coherence tomography (oct) for healthcare and life science market are Abbott Laboratories, Canon Inc., Carl Zeiss Meditec AG, Leica Microsystems GmbH, Thorlabs Inc., Edmund Optics Inc., Huvitz Co. Ltd., Santec Corporation, Topcon Medical Systems Inc., OPTOPOL Technology SA, NinePoint Medical, Wasatch Photonics Inc., Perimeter Medical Imaging AI Inc., Nidek Co. Ltd., Novacam Technologies Inc., DermaLumics, BaySpec Inc., Imalux Corporation, Lumedica, Heidelberg Engineering GmbH.
North America was the largest region in the optical coherence tomography (OCT) for healthcare and life science market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical coherence tomography (oct) for healthcare and life science market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the optical coherence tomography (oct) for healthcare and life science market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the OCT for healthcare and life science market by increasing costs of imported optical components, lasers, sensors, and precision imaging modules. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging systems, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are raising equipment procurement costs and delaying technology upgrades. However, they are also encouraging local assembly, regional supplier development, and innovation in cost-efficient OCT system designs.
The optical coherence tomography (oct) for healthcare and life science market research report is one of a series of new reports that provides optical coherence tomography (oct) for healthcare and life science market statistics, including optical coherence tomography (oct) for healthcare and life science industry global market size, regional shares, competitors with a optical coherence tomography (oct) for healthcare and life science market share, detailed optical coherence tomography (oct) for healthcare and life science market segments, market trends and opportunities, and any further data you may need to thrive in the optical coherence tomography (oct) for healthcare and life science industry. This optical coherence tomography (oct) for healthcare and life science market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Optical coherence tomography (OCT) is a non-invasive imaging method that employs light to produce high-resolution cross-sectional images of tissues. It is predominantly utilized in ophthalmology for examining the retina and identifying various eye conditions, but it also finds uses in other medical areas for in-depth tissue imaging and evaluation. This technique offers detailed, non-invasive imaging of tissues, facilitating accurate diagnosis and monitoring of conditions in both ophthalmology and other medical disciplines.
The primary categories of optical coherence tomography (OCT) used in healthcare and life sciences include catheter-based OCT devices, Doppler OCT devices, handheld OCT devices, and tabletop OCT devices. Catheter-based OCT devices are imaging instruments employed in medical procedures that provide high-resolution images of blood vessels and internal structures during minimally invasive interventions. The technology encompasses time domain OCT (TdOCT), frequency domain OCT (FdOCT), and others, with applications across fields such as ophthalmology, cardiology, dermatology, and gastroenterology. The end users of these devices include hospitals, specialty clinics, research institutions, and more.
The optical coherence tomography (OCT) for healthcare and life science markets consists of revenues earned by entities by providing services such as high-resolution imaging and diagnostics for medical conditions, including device sales, maintenance, software solutions, and technical support across various medical fields such as ophthalmology, cardiology, and dermatology. The market value includes the value of related goods sold by the service provider or included within the service offering. The optical coherence tomography (OCT) for healthcare and life science markets also includes sales of imaging systems, accessories including lenses and probes, software for data analysis, and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Characteristics
3. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Supply Chain Analysis
4. Global Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Trends and Strategies
5. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Analysis of End Use Industries
7. Global Optical Coherence Tomography (OCT) for Healthcare and Life Science Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Optical Coherence Tomography (OCT) for Healthcare and Life Science Total Addressable Market (TAM) Analysis for the Market
9. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Segmentation
10. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Regional and Country Analysis
11. Asia-Pacific Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
12. China Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
13. India Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
14. Japan Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
15. Australia Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
16. Indonesia Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
17. South Korea Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
18. Taiwan Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
19. South East Asia Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
20. Western Europe Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
21. UK Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
22. Germany Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
23. France Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
24. Italy Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
25. Spain Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
26. Eastern Europe Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
27. Russia Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
28. North America Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
29. USA Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
30. Canada Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
31. South America Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
32. Brazil Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
33. Middle East Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
34. Africa Optical Coherence Tomography (OCT) for Healthcare and Life Science Market
36. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Competitive Landscape and Company Profiles
37. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market Other Major and Innovative Companies
40. Optical Coherence Tomography (OCT) for Healthcare and Life Science Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses optical coherence tomography (oct) for healthcare and life science market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for optical coherence tomography (oct) for healthcare and life science? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The optical coherence tomography (oct) for healthcare and life science market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Catheter Based Optical Coherence Tomography (OCT) Devices; Doppler Optical Coherence Tomography (OCT) Devices; Handheld Optical Coherence Tomography (OCT) Devices; Tabletop Optical Coherence Tomography (OCT) Devices2) By Technology: Time Domain Oct (TdOct); Frequency Domain Oct (FdOct); Other Technologies
3) By Application: Ophthalmology; Cardiology; Dermatology; Gastroenterology; Other Applications
4) By End Users: Hospitals; Specialty Clinics; Research Institutes; Other End Users
Subsegments:
1) By Catheter Based Optical Coherence Tomography (OCT) Devices: Intravascular OCT (IV-OCT); Endoscopic OCT; Other Catheter-Based Devices2) By Doppler Optical Coherence Tomography (OCT) Devices: Speckle-Tracking Doppler OCT; Phase-Resolved Doppler OCT
3) By Handheld Optical Coherence Tomography (OCT) Devices: Portable Handheld OCT Systems; Compact Handheld Devices
4) By Tabletop Optical Coherence Tomography (OCT) Devices: Standalone Tabletop Systems; Modular Tabletop Devices
Companies Mentioned: Abbott Laboratories; Canon Inc.; Carl Zeiss Meditec AG; Leica Microsystems GmbH; Thorlabs Inc.; Edmund Optics Inc.; Huvitz Co. Ltd.; Santec Corporation; Topcon Medical Systems Inc.; OPTOPOL Technology SA; NinePoint Medical; Wasatch Photonics Inc.; Perimeter Medical Imaging AI Inc.; Nidek Co. Ltd.; Novacam Technologies Inc.; DermaLumics; BaySpec Inc.; Imalux Corporation; Lumedica; Heidelberg Engineering GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Optical Coherence Tomography (OCT) for Healthcare and Life Science market report include:- Abbott Laboratories
- Canon Inc.
- Carl Zeiss Meditec AG
- Leica Microsystems GmbH
- Thorlabs Inc.
- Edmund Optics Inc.
- Huvitz Co. Ltd.
- Santec Corporation
- Topcon Medical Systems Inc.
- OPTOPOL Technology SA
- NinePoint Medical
- Wasatch Photonics Inc.
- Perimeter Medical Imaging AI Inc.
- Nidek Co. Ltd.
- Novacam Technologies Inc.
- DermaLumics
- BaySpec Inc.
- Imalux Corporation
- Lumedica
- Heidelberg Engineering GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.63 Billion |
| Forecasted Market Value ( USD | $ 4.77 Billion |
| Compound Annual Growth Rate | 16.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
